Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-15-000581
Filing Date
2015-05-20
Accepted
2015-05-20 10:30:36
Documents
9
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 SIGNPATH PHARMA INC.10Q 2015-03-31 signpath.htm 10-Q 320490
2 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUAN signpathexh311.htm EX-31.1 15442
3 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUAN signpathexh321.htm EX-32.1 7491
  Complete submission text file 0001096906-15-000581.txt   1591702

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT sppxbrl-20150331.xml EX-101.INS 120074
5 XBRL SCHEMA DOCUMENT sppxbrl-20150331.xsd EX-101.SCH 20891
6 XBRL CALCULATION LINKBASE DOCUMENT sppxbrl-20150331_cal.xml EX-101.CAL 8615
7 XBRL DEFINITION LINKBASE DOCUMENT sppxbrl-20150331_def.xml EX-101.DEF 35804
8 XBRL LABELS LINKBASE DOCUMENT sppxbrl-20150331_lab.xml EX-101.LAB 79096
9 XBRL PRESENTATION LINKBASE DOCUMENT sppxbrl-20150331_pre.xml EX-101.PRE 79326
Mailing Address 3477 CORPORATE PARKWAY, SUITE 100 CENTER VALLEY PA 18034
Business Address 3477 CORPORATE PARKWAY, SUITE 100 CENTER VALLEY PA 18034 215-538-9996
SignPath Pharma, Inc. (Filer) CIK: 0001455694 (see all company filings)

EIN.: 205079533 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-158474 | Film No.: 15878476
SIC: 2834 Pharmaceutical Preparations